Sleep Disorders Trial, Recruiting NCT05340881 Sponsor: Baylor College of Medicine Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05340881
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You were diagnosed with a brain tumor and received treatment at Texas Children's Hospital
  • Your treatment included surgery alone, or surgery combined with proton beam radiation therapy
  • Your brain tumor was not one of the following types: high-grade glioma, brain stem glioma, or atypical teratoid rhabdoid tumor
  • You are currently or were previously part of a long-term study looking at thinking and learning skills in childhood brain tumor survivors at Texas Children's Hospital (confirm with trial site)
  • You are between 10 and 18 years old
  • It has been at least 1 year since your brain tumor diagnosis
  • You experience mild to moderate levels of fatigue, as measured by a specific questionnaire called the PROMIS
  • A provider from a Long-Term Survivorship program has approved your participation
  • You have good enough vision to use a computer for tasks in the study
  • You speak English
  • Your IQ score is above 70

Who may not be able to join:

  • You have been diagnosed with or treated for a new cancer in the past 12 months
  • You have had thoughts of suicide or severe depression requiring urgent care either currently or within the past 12 months
  • You have sensitivity to light, another eye condition, seizures, or migraines
  • You currently take medications that make your skin or eyes more sensitive to light
  • You have used light therapy before or are currently using it

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kimberly P Raghubar, PhD, Baylor College of Medicine

Phone: 832-822-3713

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 October 2022
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent of approached participants who consent to study participation; Percent of sessions completed during all 6 weeks of bright or dim light exposure; Percent of participants rating the intervention as acceptable by indicating that they would recommend this intervention to other survivors.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov